Darmstadt, Germany (ots/PRNewswire) - - CHMP recommendation comes in response to new biomarker data obtained from the OPUS study Merck Serono, the biopharmaceutical division of Merck, today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a ...
Vancouver, British Columbia (ots/PRNewswire) - NASDAQ: CRME TSX: COM Cardiome Pharma Corp. today announced that a publication titled, Pharmacological Cardioversion of Atrial Fibrillation with Vernakalant: Evidence in Support of the ESC Guidelines, was published in Europace, the official Journal of the European Heart ...
Düsseldorf, Germany (ots/PRNewswire) - New healthcare solutions developed with users and patients help improve the recovery process and treatment options for patients while supporting medical staff in their work Healthcare is constantly changing. The best way to deal with this change is for all parties in the sector to join forces. Philips is putting this principle into action under the banner "Transforming healthcare, ...
Laval, Quebec (ots/PRNewswire) - LumiCleanse[TM]is a clinically-proven treatment now available for all severities of acne vulgaris developed by KLOX in Canada, destined for the global acne market KLOX Technologies Inc. ("KLOX" or the "Company") is pleased to announce that it has received CE mark approval in Europe ...
Vancouver, British Columbia And Geneva (ots/PRNewswire) - - Company to host webcast and conference call today at 5:00 p.m. EST - NASDAQ: CRME TSX: COM Cardiome Pharma Corp. today announced that it has completed the acquisition of Correvio LLC ("Correvio"), a privately held pharmaceutical company headquartered in Geneva, Switzerland. Key benefits of the transaction include the following: - Accelerates Cardiome's launch of BRINAVESS(TM) (vernakalant IV) and its transformation ...
Darmstadt, Germany (ots/PRNewswire) - - New agreement marks the second collaboration between Merck and BeiGene Merck Serono, the biopharmaceutical division of Merck, today announced that a global licensing, co-development, and commercialization agreement for BeiGene-290 has been signed with BeiGene Co., Ltd., a ...
Lugano, Switzerland (ots) - Swiss Pharma Group Helsinn seals an alliance with Japanese company Chugai by granting exclusive distribution & licensing rights to commercialize its innovative phase III ghrelin receptor agonist in Germany, France, Benelux, UK and Ireland Swiss-based Helsinn group has granted Chugai ...
Shire plc & ViroPharma Incorporated
Dublin And Exton, Pennsylvania (ots/PRNewswire) - Earnings accretive, revenue growth-enhancing acquisition Shire plc and ViroPharma Incorporated today announce that their Boards of Directors have unanimously approved, and the companies have entered into, a merger agreement pursuant to which Shire will acquire all ...
Bristol-Myers Squibb GmbH & Co. KGaA
Paris, France (ots/PRNewswire) - Yervoy, an innovative immuno-oncology therapy that has demonstrated durable long-term survival in some patients,[1],[2] is now approved for use in previously-untreated patients Bristol-Myers Squibb today announced that the European Commission (EC) has approved YERVOY(R) (ipilimumab) ...
Hatfield, England (ots/PRNewswire) - Eisai announces today that it has expanded the marketing and supply agreement between its U.S. subsidiary Eisai Inc. and U.S-based Arena Pharmaceuticals Inc.'s Swiss subsidiary, Arena Pharmaceuticals GmbH, for the anti-obesity agent lorcaserin hydrochloride (lorcaserin) (U.S. ...
Lyon, France (ots/PRNewswire) - - New 9-valent HPV vaccine prevented 97% of cervical, vaginal and vulvar pre-cancers caused by five additional HPV types - Immunogenicity non-inferior to GARDASIL for original four HPV types Lyon, 4 November 2013 - Sanofi Pasteur MSD reported today that Merck's investigational ...
Berlin (ots/PRNewswire) - In the news release, "500,000 People Call for Urgent Action to Prevent Atrial Fibrillation-Related Strokes" issued on 29 Oct 2013 00:01 GMT, by Bayer Healthcare over PR Newswire, we are advised by a representative of the company that in paragraph five the words 'premature mortality from' ...
Hatfield, England (ots/PRNewswire) - First shipment to benefit more than 6 million people in 4 endemic countries Eisai announced today that it has begun the free supply of diethylcarbamazine citrate (DEC) 100 mg tablets produced at its Vizag Plant in India to the World Health Organization (WHO) in line with its ...
Berlin (ots/PRNewswire) - Atrial fibrillation is an under-diagnosed, undertreated abnormal heart rhythm that increases stroke risk five-fold compared to the general population World Stroke Day 2013 By World Stroke Day 2013 (October 29) more than 500,000 people have shown their support for the Sign Against Stroke in Atrial Fibrillation campaign, calling for urgent ...
London (ots/PRNewswire) - ViiV Healthcare today announced the submission of a regulatory application in Europe for its investigational single-tablet regimen (STR) combining dolutegravir (DTG), abacavir (ABC) and lamivudine (3TC) for the treatment of people living with HIV. This Marketing Authorisation Application ...
Frankfurt, Germany (ots/PRNewswire) - API Corporation, E-Pharma Trento and Camurus- the 2013 winners The CPhI Pharma Awards 2013 winners were announced live at the awards ceremony- day one at CPhI Worldwide [http://www.cphi.com ]. Honouring outstanding developments from some key industry players, the awards highlighted ever-advancing market innovations, fundamental to driving growth throughout global pharma. (Logo: ...
2014 International Summit of Cooperatives
Quebec City (ots/PRNewswire) - Current topics and vital issues! The 2014 International Summit of Cooperatives just unveiled a diverse and relevant program. From October 6 to 9, presentations, forums, and round tables will allow participants from around the world to discuss subjects that speak to cooperatives and mutuals of the 21st century. "The themes for this second edition of the Summit were selected to promote the ...
Frankfurt, Germany (ots/PRNewswire) - CPhI expert industry panel members highlight future implications for pharma in final part of CPhI industry report Industry to encounter drug shortages and threat of adulterated products, with pharma shifting focus to orphan drug development, low cost products and continuous processing Report's expert highlights Girish Malhotra, ...
Mechelen, Belgium And Lausanne, Switzerland (ots/PRNewswire) - Biocartis also introduces IdyllaTM, the brand name for its innovative and high-quality diagnostic platform (previously codenamed Apollo). IdyllaTM is designed to carry out fast and accurate analysis of a broad range of clinical samples[1]. The platform ...
Astellas Pharma Europe Limited
Tokyo And San Francisco (ots/PRNewswire) - - Study will be stopped early and enzalutamide offered to all qualified study participants - 30% Reduction in the Risk of Death, Hazard Ratio = 0.70 ...
Frankfurt, Germany (ots/PRNewswire) - CPhI Expert Industry Panel Members Comment on Future Contingencies for Pharma in Part II of CPhI Industry Report Pharma to change business model to include increased academic partnerships, CMO development work, more niched products, industry-wide QbD and regulation of suppliers Report's expert highlights Sam Venugopal, Director, ...
Serono Symposia International Foundation
Taormina, Italy (ots/PRNewswire) - 18-19 October 2013 Up to 70% of patients with multiple sclerosis (MS) suffer from cognitive impairment.[1] This condition frequently affects them even in the very early stages of the disease and has a negative influence on their quality of life and social functioning. Serono Symposia International Foundation (SSIF) has organized an international conference, 'Cognitive dysfunction in MS: ...
Lausanne, Switzerland, Mechelen, Belgium And Barcelona, Spain (ots/PRNewswire) - Today Biocartis and Hospital del Mar announced their licence agreement on the EGFR biomarker for colon cancer. This agreement enables Biocartis to develop a new colon cancer test, whereby a specific EGFR mutation can be rapidly and ...
The International Osteoporosis Foundation (IOF)
Nyon, Switzerland (ots) - On World Osteoporosis Day, October 20, the International Osteoporosis Foundation (IOF) is calling for women to take action now to protect their bone health. Broken bones due to osteoporosis often result in pain, immobility and loss of quality of life as well as early death. In women over 45 years of age, osteoporosis accounts for more days ...
Toshiba Medical Systems Europe
Zoetermeer, The Netherlands (ots/PRNewswire) - - Vantage Elan(TM) Toshiba Medical Systems Corporation is proud to display its revolutionary 1.5T MRI system for the first time at the Journees Francaises de la Radiologie (French Radiology Congress) which is held in the city of Paris from October the 18th to the 22nd. With more than 1,700 systems already installed worldwide, the Vantage(TM) family of MRIs provided a strong ...
Janssen-Cilag International NV (Janssen)
Beerse, Belgium (ots/PRNewswire) - Janssen-Cilag International NV (Janssen), today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor ...
Takeda Pharmaceuticals Europe Ltd
Barcelona, Spain (ots/PRNewswire) - On the occasion of the 26th European College of Neuropsychopharmacology Congress (ECNP), with educational financial support provided by Takeda and Sunovion Pharmaceuticals Europe, new data was presented showing both short and long-term efficacy for lurasidone, an atypical ...
Florence, Italy (ots/PRNewswire) - First ever Europe-wide study reveals that even when undergraduate medical students take a compulsory course on pain, they still only receive on average 12 hours' training There is an alarming lack of dedicated teaching on pain in undergraduate medical schools in Europe, according ...
Montreal (ots/PRNewswire) - Hundreds of researchers from North America, Europe, Australia and Asia have joined together in a consortium to identify the genetic basis of the five most common forms of cancer - breast, prostate, lung, ovarian and colorectal. The group, called the OncoArray Consortium, developed a new ...
Amsterdam (ots/PRNewswire) - Piramal Enterprises, Fujifilm Diosynth Biotechnologies and Vision Consulting Outline Market Predictions ADCs, multiuse facilities and regulatory transparency and integration seen as the key drivers of tomorrow's healthcare targets CPhI Worldwide [http://www.cphi.com ] and CPhI Pharma Evolution [http://www.pharmaevolution.com ], part of UBM Live's Pharmaceutical Portfolio, announce the release ...